PROMETHEUS BIOSCIENCES, INC. Operating Expenses
PROMETHEUS BIOSCIENCES, INC. reported Operating Expenses of $49.81 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. operating expenses for the quarter ending 2023-03-31 was $49.81M, a 38.30% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. operating expenses for the quarter ending 2022-12-31 was $41.98M, a 35.51% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. operating expenses for the quarter ending 2022-09-30 was $39.35M, a 41.56% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. operating expenses for the quarter ending 2022-06-30 was $35.24M, a 83.79% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. operating expenses for fiscal 2022 was $152.59M, a 67.80% increase from fiscal 2021.
- PROMETHEUS BIOSCIENCES, INC. operating expenses for fiscal 2021 was $90.93M, a 200.74% increase from fiscal 2020.
- PROMETHEUS BIOSCIENCES, INC. operating expenses for fiscal 2020 was $30.24M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2023-03-31 | $49.81M 10-Q · filed 2023-05-09 | $91.79M derived: sum of 2 quarters · filed 2023-05-09 | $131.14M derived: sum of 3 quarters · filed 2023-05-09 | $166.38M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | $41.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $81.33M derived: sum of 2 quarters · filed 2023-02-28 | $116.57M derived: sum of 3 quarters · filed 2023-02-28 | $152.59M 10-K · filed 2023-02-28 |
| 2022-09-30 | $39.35M 10-Q · filed 2022-11-09 | $74.59M derived: sum of 2 quarters · filed 2022-11-09 | $110.60M 10-Q · filed 2022-11-09 | $141.58M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | $35.24M 10-Q · filed 2022-08-11 | $71.25M 10-Q · filed 2022-08-11 | $102.23M derived: sum of 3 quarters · filed 2023-05-09 | $130.03M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | $36.02M 10-Q · filed 2023-05-09 | $67.00M derived: sum of 2 quarters · filed 2023-05-09 | $94.80M derived: sum of 3 quarters · filed 2023-05-09 | $113.97M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $30.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $58.78M derived: sum of 2 quarters · filed 2023-02-28 | $77.95M derived: sum of 3 quarters · filed 2023-02-28 | $90.93M 10-K · filed 2023-02-28 |
| 2021-09-30 | $27.80M 10-Q · filed 2022-11-09 | $46.97M derived: sum of 2 quarters · filed 2022-11-09 | $59.95M 10-Q · filed 2022-11-09 | $68.98M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $19.17M 10-Q · filed 2022-08-11 | $32.15M 10-Q · filed 2022-08-11 | $41.18M derived: sum of 3 quarters · filed 2023-02-28 | $49.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $12.98M 10-Q · filed 2022-05-12 | $22.01M derived: sum of 2 quarters · filed 2023-02-28 | $29.83M derived: sum of 3 quarters · filed 2023-02-28 | $36.56M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $16.85M derived: sum of 2 quarters · filed 2023-02-28 | $23.58M derived: sum of 3 quarters · filed 2023-02-28 | $30.24M 10-K · filed 2023-02-28 |
| 2020-09-30 | $7.83M 10-Q · filed 2021-11-12 | $14.56M derived: sum of 2 quarters · filed 2021-11-12 | $21.21M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $6.73M 10-Q · filed 2021-08-11 | $13.38M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $6.65M 10-Q · filed 2021-05-13 |